Introduction GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized weight management and type 2 diabetes treatment, helping over 1.6 million adults in England, Wales, and Scotland between early 2024 and early 2025
Side Effects : Both can cause nausea, vomiting, and gastrointestinal discomfort, which usually improve over time
Phospholipids are the same healthy fats that make up the walls of your own human cells
You may need to adjust certain medications or avoid alcohol and high-fat meals to minimize potential side effects
In addition, the toxicity of the synthesized nanocarriers with a certain amount of drug was evaluated using an MTT assay
Consult a healthcare professional before use, especially if you have underlying health conditions or are taking medications